Federal
Register Notices > Notice of
Application - 2006
>
Cedarburg Pharmaceuticals, Inc.
FR Doc E6-20690 [Federal Register: December 7, 2006 (Volume 71, Number 235)]
[Notices] [Page 70985] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07de06-77]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 9, 2006, and published in the Federal Register on June
19, 2006, (71 FR 35310--35311), Cedarburg Pharmaceuticals, Inc., 870 Badger
Circle, Grafton, Wisconsin 53024, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
Drug
|
Schedule
|
Tetrahydrocannabinols (7370)
|
I
|
Dihydromorphine (9145)
|
I
|
Oxycodone (9143)
|
II
|
Hydrocodone (9193)
|
II
|
Hydromorphone (9150)
|
II
|
The firm plans to manufacture the listed controlled substances in bulk for
distribution to its customers. By letter dated September 5, 2006, the company
has withdrawn their request for the addition of Methylphenidate (1724), to their
application for registration.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a)
and determined that the registration of Cedarburg Pharmaceuticals, Inc. to
manufacture the listed basic classes of controlled substances is consistent with
the public interest at this time. DEA has investigated Cedarburg
Pharmaceuticals, Inc. to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and testing
of the company's physical security systems, verification of the company's
compliance with State and local laws, and a review of the company's background
and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-20690 Filed 12-6-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|